ArticleFrontiers in cardiovascular medicine2026
Development and validation of a machine learning-based predictive model for new-onset atrial fibrillation after CABG.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: New-onset atrial fibrillation (NOAF) after coronary artery bypass grafting (CABG) is one of the most common post-operative complications in patients undergoing cardiac surgery and is strongly associated with adverse outcomes. We aimed to develop a machine learning (ML) model for predicting NOAF after CABG. Method: We studied 925 patients who underwent coronary artery bypass grafting (CABG). We randomly split the data into a training set (70%) and a validation set (30%). Our primary outcome was new-onset atrial fibrillation (NOAF) after surgery (i.e., the first episode of atrial fibrillation within 7 days post-operatively in patients who were in sinus rhythm before CABG). We developed eight predictive models based on machine learning algorithms and evaluated their performance using area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, F1 score, and the Youden index. SHapley Additive exPlanations (SHAP) values were computed and plotted to interpret the contribution of individual features to model predictions. Results: The incidence of NOAF was 19%. For predicting new-onset atrial fibrillation after CABG, the Gradient Boosting model achieved the highest AUC [0.842 (0.785-0.899)], outperforming the logistic regression model [0.790 (0.722-0.858)]. In addition, AUCs of all machine learning models [0.761-0.842] exceeded those of conventional risk scores, such as CHA2DS2-VASc and HATCH [0.587 (0.55-0.724), 0.62 (0.543-0.697), respectively]. Conclusion: The key features selected by machine learning methods and the resulting predictive models can predict new-onset atrial fibrillation after CABG with reasonable accuracy, which may support exploratory risk stratification and hypothesis generation; external validation is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.